Lupin sees significant upside from $150-million Symbiomix acquisition
NewsNews / News 7 years ago 524 Views comments
The drugmaker expects a fillip from the USD 1 billion market that Solosec, Symbiomixâs lead product, addresses.
Related Posts
Free public discourse from all forms of violence: President Pranab Mukherjee in last address to nation
Comments